Durvalumab in Combination with Bacillus Calmette-Guérin Induction and Maintenance Therapy for Bacillus Calmette-Guérin-Naïve, High-Risk Non-muscle-Invasive Bladder Cancer: Expanded Efficacy and Safety Analyses from POTOMAC: Erratum.

Shore ND, Nishiyama H, Redorta JP, Krawczyński M, Seyitkuliev A, Novikov A, Guerrero-Ramos F, Kato M, Goeman L, Hellmis E, Powles T, Gust KM, Vasey P, Bigot P, Fradet Y, Zielinski R, Deturmeny J, Kulkarni G, Hunting J, Rao-Melacini P, Boulos S, Marsh AK, De Santis M

Open source

DOI: 10.1097/ju.0000000000005170
Published: 2026 Oct
Container: The Journal of urology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/ju.0000000000005170,
  title = {Durvalumab in Combination with Bacillus Calmette-Guérin Induction and Maintenance Therapy for Bacillus Calmette-Guérin-Naïve, High-Risk Non-muscle-Invasive Bladder Cancer: Expanded Efficacy and Safety Analyses from POTOMAC: Erratum.},
  author = {Shore ND and Nishiyama H and Redorta JP and Krawczyński M and Seyitkuliev A and Novikov A and Guerrero-Ramos F and Kato M and Goeman L and Hellmis E and Powles T and Gust KM and Vasey P and Bigot P and Fradet Y and Zielinski R and Deturmeny J and Kulkarni G and Hunting J and Rao-Melacini P and Boulos S and Marsh AK and De Santis M},
  year = {2026},
  journal = {The Journal of urology},
  doi = {10.1097/ju.0000000000005170},
  url = {https://doi.org/10.1097/ju.0000000000005170}
}

RIS

TY  - JOUR
TI  - Durvalumab in Combination with Bacillus Calmette-Guérin Induction and Maintenance Therapy for Bacillus Calmette-Guérin-Naïve, High-Risk Non-muscle-Invasive Bladder Cancer: Expanded Efficacy and Safety Analyses from POTOMAC: Erratum.
AU  - Shore ND
AU  - Nishiyama H
AU  - Redorta JP
AU  - Krawczyński M
AU  - Seyitkuliev A
AU  - Novikov A
AU  - Guerrero-Ramos F
AU  - Kato M
AU  - Goeman L
AU  - Hellmis E
AU  - Powles T
AU  - Gust KM
AU  - Vasey P
AU  - Bigot P
AU  - Fradet Y
AU  - Zielinski R
AU  - Deturmeny J
AU  - Kulkarni G
AU  - Hunting J
AU  - Rao-Melacini P
AU  - Boulos S
AU  - Marsh AK
AU  - De Santis M
PY  - 2026
JO  - The Journal of urology
DO  - 10.1097/ju.0000000000005170
UR  - https://doi.org/10.1097/ju.0000000000005170
ER  -

APA

ND, S., H, N., JP, R., M, K., A, S., A, N., F, G., M, K., L, G., E, H., T, P., KM, G., P, V., P, B., Y, F., R, Z., J, D., G, K., J, H., P, R., S, B., AK, M., & M, D. S. (2026). Durvalumab in Combination with Bacillus Calmette-Guérin Induction and Maintenance Therapy for Bacillus Calmette-Guérin-Naïve, High-Risk Non-muscle-Invasive Bladder Cancer: Expanded Efficacy and Safety Analyses from POTOMAC: Erratum.. The Journal of urology. https://doi.org/10.1097/ju.0000000000005170

Source records

pubmed · retrieved 2026-11-10T19:10:04.397Z